(Q66957673)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:498423%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

title

Treatment of acute nonlymphoblastic leukemia in adults with daunorubicin-DNA complex: a preliminary report (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:498423%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

Treatment of acute nonlymphoblastic leukemia in adults with daunorubicin-DNA complex: A preliminary report (English)

1 reference

12 June 2023

1 reference

12 June 2023

1 reference

12 June 2023

17

J Palmblad

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:498423%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

7

B Gullbring

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:498423%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

author name string

G. Gahrton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

M. Björkholm

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

G. Brenning

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

I. Christenson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

L. Engstedt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

S. Franzén

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

G. Holm

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

C. Högman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

P. Hörnsten

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

S. Jameson

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

A. Killander

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

C. Simonsson-Lindemalm

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

D. Lockner

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

B. Lönnqvist

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

H. Mellstedt

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

C. Paul

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

C. Pauli

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

C. Peterson

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

P. Reizenstein

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

B. Simonsson

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

K. O. Skårberg

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

A. M. Udén

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

B. Wadman

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498423

7 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=498423

7 July 2022

publication date

1 January 1979

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:498423%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

1 September 2019

http://link.springer.com/content/pdf/10.1007/BF00253109.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00253109/fulltext.html

12 June 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00253109

12 June 2023

1 reference

Cancer Chemotherapy and Pharmacology

12 June 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:498423%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:498423%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:498423%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

page(s)

73-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:498423%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00253109

1 September 2019

exact match

0 references

cites work

Daunorubicin-DNA: Further clinical trials in acute non-lymphoblastic leukemia

1 reference

12 December 2020

Decreased cardiac toxicity of adriamycin and daunorubicin when bound to DNA

1 reference

12 December 2020

Clinical trials with daunorubincin-DNA and adriamycin-DNA in acute lymphoblastic leukemia of childhood, acute nonlymphoblastic leukemia, and bronchogenic carcinoma

1 reference

12 December 2020

L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia

1 reference

12 December 2020

Rubidomycin. A new agent active in the treatment of acute lymphoblastic leukaemia

1 reference

12 December 2020

Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases

1 reference

12 December 2020

Daunorubicin in the therapy of acute granulocytic leukemia

1 reference

12 December 2020

Letter: DNA-daunorubicin complex: preliminary trials in human leukaemia.

1 reference

12 December 2020

Chemotherapy through Lysosomes with a DNA-Daunorubicin Complex

1 reference

12 December 2020

Experimental leukemia chemotherapy with a "lysosomotropic" adriamycin-DNA complex.

1 reference

12 December 2020

A clinicopathologic analysis of adriamycin cardiotoxicity

1 reference

12 December 2020

Combination Chemotherapy using L-Asparaginase, Daunorubicin, and Cytosine Arabinoside in Adults with Acute Myelogenous Leukaemia

1 reference

12 December 2020